263 related articles for article (PubMed ID: 18712716)
1. Unmethylated E-cadherin gene expression is significantly associated with metastatic human prostate cancer cells in bone.
Saha B; Kaur P; Tsao-Wei D; Naritoku WY; Groshen S; Datar RH; Jones LW; Imam SA
Prostate; 2008 Nov; 68(15):1681-8. PubMed ID: 18712716
[TBL] [Abstract][Full Text] [Related]
2. Overexpression of E-cadherin and beta-catenin proteins in metastatic prostate cancer cells in bone.
Saha B; Arase A; Imam SS; Tsao-Wei D; Naritoku WY; Groshen S; Jones LW; Imam SA
Prostate; 2008 Jan; 68(1):78-84. PubMed ID: 18008331
[TBL] [Abstract][Full Text] [Related]
3. Overexpression of E-cadherin protein in metastatic breast cancer cells in bone.
Saha B; Chaiwun B; Imam SS; Tsao-Wei DD; Groshen S; Naritoku WY; Imam SA
Anticancer Res; 2007; 27(6B):3903-8. PubMed ID: 18225549
[TBL] [Abstract][Full Text] [Related]
4. E-cadherin expression in prostate cancer: a broad survey using high-density tissue microarray technology.
Rubin MA; Mucci NR; Figurski J; Fecko A; Pienta KJ; Day ML
Hum Pathol; 2001 Jul; 32(7):690-7. PubMed ID: 11486167
[TBL] [Abstract][Full Text] [Related]
5. Association of E-cadherin and beta-catenin with metastasis in nasopharyngeal carcinoma.
Li Z; Ren Y; Lin SX; Liang YJ; Liang HZ
Chin Med J (Engl); 2004 Aug; 117(8):1232-9. PubMed ID: 15361301
[TBL] [Abstract][Full Text] [Related]
6. Decreased expression of E-cadherin in the progression of rat prostatic cancer.
Bussemakers MJ; van Moorselaar RJ; Giroldi LA; Ichikawa T; Isaacs JT; Takeichi M; Debruyne FM; Schalken JA
Cancer Res; 1992 May; 52(10):2916-22. PubMed ID: 1581909
[TBL] [Abstract][Full Text] [Related]
7. Expression of the cellular adhesion molecule E-cadherin is reduced or absent in high-grade prostate cancer.
Umbas R; Schalken JA; Aalders TW; Carter BS; Karthaus HF; Schaafsma HE; Debruyne FM; Isaacs WB
Cancer Res; 1992 Sep; 52(18):5104-9. PubMed ID: 1516067
[TBL] [Abstract][Full Text] [Related]
8. E-cadherin and DAP kinase in pancreatic adenocarcinoma and corresponding lymph node metastases.
Dansranjavin T; Möbius C; Tannapfel A; Bartels M; Wittekind C; Hauss J; Witzigmann H
Oncol Rep; 2006 May; 15(5):1125-31. PubMed ID: 16596173
[TBL] [Abstract][Full Text] [Related]
9. [Studies of promoter methylation status and protein expression of E-cadherin gene in associated progression stages of gastric cancer].
Zheng ZH; Sun XJ; Ma MC; Hao DM; Liu YH; Sun KL
Yi Chuan Xue Bao; 2003 Feb; 30(2):103-8. PubMed ID: 12776596
[TBL] [Abstract][Full Text] [Related]
10. Epigenetic changes induced by reactive oxygen species in hepatocellular carcinoma: methylation of the E-cadherin promoter.
Lim SO; Gu JM; Kim MS; Kim HS; Park YN; Park CK; Cho JW; Park YM; Jung G
Gastroenterology; 2008 Dec; 135(6):2128-40, 2140.e1-8. PubMed ID: 18801366
[TBL] [Abstract][Full Text] [Related]
11. E-cadherin abnormalities resulting from CPG methylation promoter in metastatic and nonmetastatic oral cancer.
de Moraes RV; Oliveira DT; Landman G; de Carvalho F; Caballero O; Nonogaki S; Nishimoto I; Kowalski LP
Head Neck; 2008 Jan; 30(1):85-92. PubMed ID: 17685455
[TBL] [Abstract][Full Text] [Related]
12. Aberrant methylation of E-cadherin and H-cadherin genes in nonsmall cell lung cancer and its relation to clinicopathologic features.
Kim DS; Kim MJ; Lee JY; Kim YZ; Kim EJ; Park JY
Cancer; 2007 Dec; 110(12):2785-92. PubMed ID: 17960794
[TBL] [Abstract][Full Text] [Related]
13. E-cadherin expression is silenced by DNA hypermethylation in human breast and prostate carcinomas.
Graff JR; Herman JG; Lapidus RG; Chopra H; Xu R; Jarrard DF; Isaacs WB; Pitha PM; Davidson NE; Baylin SB
Cancer Res; 1995 Nov; 55(22):5195-9. PubMed ID: 7585573
[TBL] [Abstract][Full Text] [Related]
14. P-Cadherin is a basal cell-specific epithelial marker that is not expressed in prostate cancer.
Jarrard DF; Paul R; van Bokhoven A; Nguyen SH; Bova GS; Wheelock MJ; Johnson KR; Schalken J; Bussemakers M; Isaacs WB
Clin Cancer Res; 1997 Nov; 3(11):2121-8. PubMed ID: 9815605
[TBL] [Abstract][Full Text] [Related]
15. E-cadherin expression is silenced by 5' CpG island methylation in acute leukemia.
Corn PG; Smith BD; Ruckdeschel ES; Douglas D; Baylin SB; Herman JG
Clin Cancer Res; 2000 Nov; 6(11):4243-8. PubMed ID: 11106238
[TBL] [Abstract][Full Text] [Related]
16. Increased expression of bone morphogenetic protein-7 in bone metastatic prostate cancer.
Masuda H; Fukabori Y; Nakano K; Takezawa Y; CSuzuki T; Yamanaka H
Prostate; 2003 Mar; 54(4):268-74. PubMed ID: 12539225
[TBL] [Abstract][Full Text] [Related]
17. [Studies on gene expression and the 5' CpG islands methylation status of E-cadherin in acute myeloid leukemia].
Gao F; Li Y; Liu W; Lu XL; Li X; Wang PP; Liu YP
Zhonghua Xue Ye Xue Za Zhi; 2006 Jan; 27(1):25-7. PubMed ID: 16732935
[TBL] [Abstract][Full Text] [Related]
18. Epigenetic control of E-cadherin (CDH1) by CpG methylation in metastasising laryngeal cancer.
Azarschab P; Stembalska A; Loncar MB; Pfister M; Sasiadek MM; Blin N
Oncol Rep; 2003; 10(2):501-3. PubMed ID: 12579297
[TBL] [Abstract][Full Text] [Related]
19. N-myc downstream regulated gene-1/Cap43 may play an important role in malignant progression of prostate cancer, in its close association with E-cadherin.
Song Y; Oda Y; Hori M; Kuroiwa K; Ono M; Hosoi F; Basaki Y; Tokunaga S; Kuwano M; Naito S; Tsuneyoshi M
Hum Pathol; 2010 Feb; 41(2):214-22. PubMed ID: 19800102
[TBL] [Abstract][Full Text] [Related]
20. The role of an 80 kDa fragment of E-cadherin in the metastatic progression of prostate cancer.
Kuefer R; Hofer MD; Gschwend JE; Pienta KJ; Sanda MG; Chinnaiyan AM; Rubin MA; Day ML
Clin Cancer Res; 2003 Dec; 9(17):6447-52. PubMed ID: 14695147
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
